Value of Plasmatic Membrane Attack Complex as a Marker of Severity in Acute Kidney Injury

The aim of this study was to determine if complement pathway is activated in AKI; for this purpose, we measured, through ELISA sandwich, the terminal lytic fraction of the complement system, called membrane attack complex (C5b-C9), in AKI patients compared with patients with similar clinical conditi...

Full description

Bibliographic Details
Main Authors: Eva Rodríguez, Marta Riera, Clara Barrios, Julio Pascual
Format: Article
Language:English
Published: Hindawi Limited 2014-01-01
Series:BioMed Research International
Online Access:http://dx.doi.org/10.1155/2014/361065
id doaj-53675810bb7145c7a2a1b08cd0d65ec9
record_format Article
spelling doaj-53675810bb7145c7a2a1b08cd0d65ec92020-11-24T20:41:20ZengHindawi LimitedBioMed Research International2314-61332314-61412014-01-01201410.1155/2014/361065361065Value of Plasmatic Membrane Attack Complex as a Marker of Severity in Acute Kidney InjuryEva Rodríguez0Marta Riera1Clara Barrios2Julio Pascual3Departamento de Nefrología, Hospital del Mar, Passeig Marítim 25-29, 08003 Barcelona, SpainDepartamento de Nefrología, Hospital del Mar, Passeig Marítim 25-29, 08003 Barcelona, SpainDepartamento de Nefrología, Hospital del Mar, Passeig Marítim 25-29, 08003 Barcelona, SpainDepartamento de Nefrología, Hospital del Mar, Passeig Marítim 25-29, 08003 Barcelona, SpainThe aim of this study was to determine if complement pathway is activated in AKI; for this purpose, we measured, through ELISA sandwich, the terminal lytic fraction of the complement system, called membrane attack complex (C5b-C9), in AKI patients compared with patients with similar clinical conditions but normal renal function. Our data showed that complement system is activated in AKI. Plasmatic MAC concentrations were significantly higher in AKI patients than in those with normal renal function; this difference is maintained independently of the AKI etiology and is proportional to the severity of AKI, measured by ADQI classification. In addition, we found that plasmatic MAC concentrations were significantly higher in patients who did not recover renal function at time of hospitalization discharge, in patients who died during the acute process, and in patients who need renal replacement therapy during hospitalization, but in this last group, the differences did not reach statistical significance. In conclusion, plasmatic MAC concentration seems valuable as a marker of AKI severity.http://dx.doi.org/10.1155/2014/361065
collection DOAJ
language English
format Article
sources DOAJ
author Eva Rodríguez
Marta Riera
Clara Barrios
Julio Pascual
spellingShingle Eva Rodríguez
Marta Riera
Clara Barrios
Julio Pascual
Value of Plasmatic Membrane Attack Complex as a Marker of Severity in Acute Kidney Injury
BioMed Research International
author_facet Eva Rodríguez
Marta Riera
Clara Barrios
Julio Pascual
author_sort Eva Rodríguez
title Value of Plasmatic Membrane Attack Complex as a Marker of Severity in Acute Kidney Injury
title_short Value of Plasmatic Membrane Attack Complex as a Marker of Severity in Acute Kidney Injury
title_full Value of Plasmatic Membrane Attack Complex as a Marker of Severity in Acute Kidney Injury
title_fullStr Value of Plasmatic Membrane Attack Complex as a Marker of Severity in Acute Kidney Injury
title_full_unstemmed Value of Plasmatic Membrane Attack Complex as a Marker of Severity in Acute Kidney Injury
title_sort value of plasmatic membrane attack complex as a marker of severity in acute kidney injury
publisher Hindawi Limited
series BioMed Research International
issn 2314-6133
2314-6141
publishDate 2014-01-01
description The aim of this study was to determine if complement pathway is activated in AKI; for this purpose, we measured, through ELISA sandwich, the terminal lytic fraction of the complement system, called membrane attack complex (C5b-C9), in AKI patients compared with patients with similar clinical conditions but normal renal function. Our data showed that complement system is activated in AKI. Plasmatic MAC concentrations were significantly higher in AKI patients than in those with normal renal function; this difference is maintained independently of the AKI etiology and is proportional to the severity of AKI, measured by ADQI classification. In addition, we found that plasmatic MAC concentrations were significantly higher in patients who did not recover renal function at time of hospitalization discharge, in patients who died during the acute process, and in patients who need renal replacement therapy during hospitalization, but in this last group, the differences did not reach statistical significance. In conclusion, plasmatic MAC concentration seems valuable as a marker of AKI severity.
url http://dx.doi.org/10.1155/2014/361065
work_keys_str_mv AT evarodriguez valueofplasmaticmembraneattackcomplexasamarkerofseverityinacutekidneyinjury
AT martariera valueofplasmaticmembraneattackcomplexasamarkerofseverityinacutekidneyinjury
AT clarabarrios valueofplasmaticmembraneattackcomplexasamarkerofseverityinacutekidneyinjury
AT juliopascual valueofplasmaticmembraneattackcomplexasamarkerofseverityinacutekidneyinjury
_version_ 1716825475807969280